The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER: RESULTS OF THE CAPSURE DATABASE
Abstract
PURPOSE: We determine whether urologists caring for men with prostate cancer accurately captured the nuances of quality of life, as disclosed by patients in validated, self-administered health related quality of life instruments. MATERIALS AND METHODS: We analyzed information on 2,252 patients 42 to 95 years old enrolled in CaPSURE, a large, observational cancer of the prostate strategic urological research endeavor database, in which men with all stages of prostate cancer are followed quarterly with standardized validated written surveys to assess clinical parameters, symptoms and health related quality of life. At each visit urologists recorded Karnofsky performance status rating and the presence or absence of various symptoms, such as fatigue, pain and dysfunction in the sexual, urinary and bowel domains. Within 30 days of the visit patients independently completed self-administered health related quality of life instruments, including the RAND 36-Item Health Survey and University of California, Los Angeles Prostate Cancer Index, in which scores of 80 to 100 and 0 to 79 were interpreted as absence of impairment and moderate to severe impairment, respectively. Using chi-square analysis we compared symptoms, as recorded by the urologist, with health related quality of life impairment in relevant domains, as reported by the patient. RESULTS: Significant differences (p < or = 0.002) were noted between physician and patient assessment of clinical domains, such as physical, sexual, urinary and bowel function, fatigue and bone pain. In all domains urologists underestimated patient symptoms, causing health related quality of life impairment. CONCLUSIONS: In men with early stage and advanced prostate cancer physician ratings of patient symptoms do not correlate well with patient self-assessments of health related quality of life. Hence, urologists should attempt to elucidate more completely the components of patient quality of life after the diagnosis and treatment of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
The rand 36‐item health survey 1.0
Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993) · Health Economics · doi:10.1002/hec.4730020305 · Cited by 2,884
Assessment of Quality-of-Life Outcomes
Testa, M. A., & Simonson, D. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341306 · Cited by 2,551
Motamedi, K. K., Campbell, A., Converse, P. E., & Rodgers, W. L. (1977) · The Academy of Management Review · doi:10.2307/257525 · Cited by 1,954
Evaluation of Chemotherapeutic Agents.
(1950) · Archives of Internal Medicine · doi:10.1001/archinte.1950.00230180176018 · Cited by 1,133
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Self-citationEvaluation of chemotherapeutic agents
A.R.L. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90056-8 · Cited by 1,004
Cited by
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555
(1999) · National Academies Press eBooks · doi:10.17226/6467 · Cited by 526
Haglind, E., Carlsson, S., Stranne, J., Wallerstedt, A., Wilderäng, U., Thorsteinsdottir, T., Lagerkvist, M., Damber, J.-E., Bjartell, A., Hugosson, J., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.02.029 · Cited by 497
Erectile Dysfunction in Diabetes Mellitus
Malavige, L. S., & Levy, J. C. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01168.x · Cited by 444
Metadata
- Authors
- LITWIN, M. S., LUBECK, D. P., HENNING, J. M., & CARROLL, P. R.
- Venue
- Journal of Urology
- Published
- 1998-06
- Volume
- 159
- Issue
- 6
- Pages
- 1988-1992
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W1968864845
- Cited by
- 401
- References
- 23
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER: RESULTS OF THE CAPSURE DATABASE. https://app.cochat.ai/papers/10.1016/s0022-5347(01)63222-1
- The paper
- LITWIN, M. S., LUBECK, D. P., HENNING, J. M., & CARROLL, P. R. (1998). DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER: RESULTS OF THE CAPSURE DATABASE. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)63222-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.